Loading provider…
Loading provider…
Neurology Physician in Tampa, FL
NPI: 1265455315Primary Practice Location
TAMPA GENERAL HOSPITAL
1 Tampa General Cir, Tampa, FL
Primary Employer
University Medical Service Association Inc
health.usf.edu
HQ Phone
Get MD Theresa's Phone Numberphone_androidMobile
Get MD Theresa's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1993 - 2026
NY State Medical License
1991 - 1994

American Board of Psychiatry and Neurology
Neurology
Rutgers New Jersey Medical School
njms.rutgers.edu
Medical School
Until 1988
SUNY Downstate Health Sciences University
downstate.edu
Residency • Neurology
1989 - 1992
Rutgers Health
Internship • Transitional Year
1988 - 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 109 | 132 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 47 | 50 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 35 | 35 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 28 | 28 |
| 5 | 64616Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | 19 | 36 |
Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.
Authors: L Wecker, M Engberg, R Philpot, C Lambert, C Kang, J Antilla, P Bickford, C Hudson, T Zesiewicz, Peter Rowell
Publication Date: 2012-12-18
Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease
Lead Sponsor: VA Office of Research and Development
Intervention / Treatment: DRUG: Quetiapine, DRUG: Pimavanserin
Lead Sponsor: Biogen
Intervention / Treatment: DRUG: BIIB132-Matching Placebo, DRUG: BIIB132
Lead Sponsor: Jazz Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: CX-8998